Nuclear Medicine and Molecular Imaging is a growing medical specialty with an increasing impact internationally, and with ever so more positive results especially in cancer patients, at a diagnostic and therapeutical level. A cutting-edge cancer hospital like the GOC has consciously opted from the very beginning to go ahead with the development of a modern nuclear medicine unit.
The PET / CT examination enables us to detect disorders at the functional and molecular level, which often precede anatomical lesions. This allows us to diagnose pathological conditions at an earlier stage and/or to monitor without the delay the response to treatment. This has a significant benefit for the patient.
In addition to PET / CT, in the chamber of radioactive isotopes we offer established (eg radioactive iodine for benign and malignant thyroid diseases) and more innovative treatments (eg Xofigo for bone marrow cancer, metastatic cancer, metastatic cancer).
But beyond that, we have incorporated “Theragnostics”, (which derive from Therapy and Diagnostics) as a kind of portfolio of products which aim to transform individualized patient care in oncology through targeted molecular radiotherapy and molecular imaging diagnostic products.
Our Center is one of the few in the world today, which provides some of the most innovative treatments with 177Lu-PSMA and 225Ac-PSMA in adults with castration resistant prostate cancer, having previously with diagnostics tools located and “locked” with huge precision “tumor-target”.
For the good of each and every patient, we combine our practice with continuous education and training, aiming always for the best. It is also imperative for us that all services will be accessible to those in need, with no discrimination whatsoever.
Alexis was born in 1984 in Nicosia, Cyprus. He is married, commutes everyday to and from Limassol, is a keen football player, and fluent in Greek, German and English.